Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revlimid and Rituximab in Relapsed/Refractory CLL
NCT01199575Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- Aug 2010
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in chronic lymphocytic leukemia (CLL), sponsored by University of California, San Diego. Started Aug 2010; status: completed.
02
Drugs
lenalidomide
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01199575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01199575.